Edition:
United States

People: Biogen Inc (BIIB.O)

BIIB.O on Nasdaq

250.04USD
22 May 2017
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$250.04
Open
$250.69
Day's High
$251.00
Day's Low
$249.01
Volume
1,331,175
Avg. Vol
1,645,867
52-wk High
$333.65
52-wk Low
$223.02

Schenk, Lynn 

Ms. Lynn Schenk, J.D. is an Independent Director of the Company. Ms. Schenk served as a director of the Company from 1995 to 2003 during the period the Company was operated as IDEC Pharmaceuticals, and has served as a director since 2003 following IDEC’s merger with Biogen Inc. Ms. Schenk is an attorney and consultant in private practice with extensive public policy and business experience. She is also a member of the Board of Overseers of the Scripps Research Institute, a director of the California High Speed Rail Authority Board, and a trustee of the University of California, San Diego Foundation. From 1999 to 2003, she served as Chief of Staff to the Governor of California, during which time she led the effort to create the Institutes for Science and Innovation at the University of California. She headed the State’s Executive Branch risk management team post 9/11 and during the California energy crisis. From 1993 to 1995, Ms. Schenk was a Member of the United States House of Representatives, representing San Diego, California and served on the House Energy & Commerce Committee with a special emphasis on biotechnology. From 1980 to 1983, she was the California Secretary of Business, Transportation and Housing during which time she formed the California Commission on Industrial Innovation. Ms. Schenk is a member of the Board of Directors of Sempra Energy, an energy services and development company, and serves on the Compensation Committee and Environmental Health, Safety and Technology Committee of which she is the Chair.

Basic Compensation

Total Annual Compensation, USD 160,000
Restricted Stock Awards, USD 269,420
Long-Term Incentive Plans, USD --
All Other, USD 25,000
Fiscal Year Total, USD 454,420

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Stelios Papadopoulos

627,630

Michel Vounatsos

5,801,050

Paul Clancy

5,385,200

Kenneth Di Pietro

3,989,900

Susan Alexander

4,167,300

Michael Ehlers

5,512,540
As Of  30 Dec 2016